Elicio Therapeutics, Inc. Stock Performance

Open $1.85	Prev. Close $1.81	Circuit Range N/A
Day Range $1.78 - $1.92	Year Range $1.72 - $16.00	Volume 7,207
Average Traded $1.86

Elicio Therapeutics, Inc. Share Price Today

As of 10 October 2026, Elicio Therapeutics, Inc.'s share price is $1.92. The stock opened at $1.85, compared to its previous close of $1.81. During today's trading session, Elicio Therapeutics, Inc.'s share price traded between $1.78 and $1.92, with an average price of $1.85. Over the past 52 weeks, the stock has recorded a high of $16.00 and a low of $1.72. In terms of performance, Elicio Therapeutics, Inc.'s share price has declined by 81.93% over the last six months and is down 79.45% on a year-on-year basis.

Elicio Therapeutics, Inc. Share Price Chart

$1.78$1.92

Elicio Therapeutics, Inc. Stock Fundamentals & Key Indicators

Market Cap $29.32M	PE Ratio (TTM) N/A	Dividend Yield 0.00%
EPS (TTM) $-1.44	Revenue (TTM) $0.00	Return On Equity (TTM) -476.77%
Profit Margin N/A	Debt to Equity 1.20	Quarterly Earnings Growth YoY 18.45%

Elicio Therapeutics, Inc. Quarterly Profit & Loss

All figures in USD

Particulars	Sep 2025	Dec 2025	Mar 2026	Jun 2026
Revenue	$0.00	$0.00	$0.00	$0.00
Net Profit	-$10.08	-$7.72	-$11.82	-$8.22
Net Profit Margin	N/A	N/A	N/A	N/A
Income Change	N/A	23.41%	-53.11%	30.46%

Elicio Therapeutics, Inc. Annual Profit & Loss

All figures in USD

Particulars	2023	2024	2025
Revenue	$0.00	$0.00	$0.00
Net Profit	-$35.20	-$51.90	-$39.57
Net Profit Margin	N/A	N/A	N/A
Income Change	N/A	-47.44%	23.76%

About Elicio Therapeutics, Inc.

Elicio Therapeutics Inc is a clinical-stage biotechnology company advancing novel immunotherapies for the treatment of cancer, including mKRAS-positive pancreatic cancer, colorectal cancer (CRC), lung cancer, and other mKRAS-positive cancers. The Company focuses on developing effective, off-the-shelf immunotherapies using its proprietary Amphiphile (AMP) technology, which aims to enhance the education, activation, and amplification of cancer-specific T cells to promote durable cancer immunosurveillance. Its clinical pipeline includes ELI-002 7P, a lymph node-targeted cancer immunotherapy currently being evaluated in a Phase 2 study for mKRAS pancreatic ductal adenocarcinoma (PDAC), a common form of pancreatic cancer.

Elicio Therapeutics, Inc. Historical Returns

Month	Open	Close	Change %
Oct 2026	$1.85	$1.92	+4.93%
Sep 2026	$2.65	$1.82	-39.17%
Aug 2026	$2.84	$3.00	+6.95%
Jul 2026	$3.98	$2.81	-28.63%
Jun 2026	$11.53	$3.93	-65.16%
May 2026	$10.65	$11.28	+6.42%
Apr 2026	$10.78	$10.60	-1.21%
Mar 2026	$13.34	$10.73	-18.03%
Feb 2026	$7.91	$13.09	+69.23%
Jan 2026	$7.99	$7.74	-2.83%
Dec 2025	$9.27	$7.96	-14.64%
Nov 2025	$9.21	$9.32	+0.05%

ELTX Share Price FAQs

What is Elicio Therapeutics, Inc. share price today?

Elicio Therapeutics, Inc. share price today is $1.92 as on October 10, 2026 at 12:38 am IST.

What is the 52 week high and 52 week low of Elicio Therapeutics, Inc. stock?

The 52 week high of Elicio Therapeutics, Inc. stock is $16.00, while the 52 week low is $1.72 as of 10 Oct '26.

What is ELTX's market capitalisation today?

ELTX market capitalisation is $29.32M as of October 10, 2026, at 12:41 am IST.

What is ELTX's net income for the last quarter?

ELTX's net income for the last quarter is -8.22B USD.

What is the 5 year returns of ELTX?

The 5 year returns of ELTX is -95.41% as on 10 Oct '26.

What is the high & low stock price of ELTX today?

ELTX stock price hit a high of $1.92 and low of $1.78 as of 10 Oct '26.

Can I buy ELTX shares in India?

Yes. You can buy ELTX in India by opening an international trading account.